Bombardier stock to redeem USD 750 million of 2030 notes
Ondas stock: Q3 revenue hits $167.5 million, outlook raised
Nouveau Monde Graphite stock advances Matawinie mine construction
Las Vegas Sands stock faces higher service caps at Sands China
Semtech stock: TD Cowen cuts target to USD 145, keeps Buy
Alnylam Pharmaceuticals stock target cut to 250 dollars by H.C. Wainwright
Munich Re's Digital Push and Annuity Shield Cut No Ice With Jefferies' 550-Euro Stance
XRP's Two Outflow Stories Don't Add Up to the Same Thing
Riot Platforms stock: Bernstein sees 50% AI value discount
Immunic stock: Q3 loss widens ahead of December trial data
Cable One stock faces NYSE compliance plan after listing notice
Denali Therapeutics stock gets stronger AVLAYAH outlook
ATCO stock: ACCC grants waiver in Emera merger review
Kohl's stock: Telsey lifts price target to USD 25
Ballard Power Systems stock: Q3 revenue falls 31%, margin rises
BlackBerry stock gets QNX lift as backlog rises by USD 250 million
Vulcan Energy's Lionheart: EIB Sees 12% of EU Lithium Hydroxide Demand by 2030
Madrigal Pharmaceuticals stock: New F4 study, late-2027 readout
BioCryst stock: ORLADEYO data show fewer HAE-related visits
Piper Sandler cuts General Mills stock to Neutral over dividend risk
Hydro One stock target raised to CAD 58 by BMO
Paychex stock: PEO shift gains momentum at J.P. Morgan conference
Curis stock: Q3 results mark latest emavusertib update
Biogen stock: Five-year lecanemab data show slower progression
Orchid Island Capital stock keeps November dividend at USD 0.10
Xiaomi Faces Twin Test: EV Delivery Ambitions and Premium Phone Push Ahead of November 24 Results
AECOM stock sets margin record as fiscal 2027 outlook starts
Lenzing's Alabama Bet and Heiligenkreuz Deadline Test the Durability of Its Margin
Deutz Defies Market Jitters as Defence Arm Promises €1 Billion-Plus Payday
Gold's Asian Demand Story Cracks as Chinese ETFs Post First Outflows
BYD Marks 19-Millionth NEV as Wang Pitches Local Roots Abroad
Bayer Balances Biologics Push and $672 Million Loss Against Raised Guidance
BioNTech Offloads Roche R&D Costs From 2027 as Patent Suits Widen and Melbourne Plant Opens